PROteolysis Targeting Chimera (PROTAC) Market, Global Outlook and Forecast 2022-2028
A proteolysis targeting chimera (PROTAC) is a heterobifunctional small molecule composed of two active domains and a linker capable of removing specific unwanted proteins. Rather than acting as a conventional enzyme inhibitor, a PROTAC works by inducing selective intracellular proteolysis. PROTACs consist of two covalently linked protein-binding molecules: one capable of engaging an E3 ubiquitin ligase, and another that binds to a target protein meant for degradation. Recruitment of the E3 ligase to the target protein results in ubiquitination and subsequent degradation of the target protein by the proteasome. Because PROTACs need only to bind their targets with high selectivity (rather than inhibit the target protein's enzymatic activity), there are currently many efforts to retool previously ineffective inhibitor molecules as PROTACs for next-generation drugs.
This report contains market size and forecasts of PROteolysis Targeting Chimera (PROTAC) in global, including the following market information:
Global PROteolysis Targeting Chimera (PROTAC) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PROteolysis Targeting Chimera (PROTAC) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five PROteolysis Targeting Chimera (PROTAC) companies in 2021 (%)
The global PROteolysis Targeting Chimera (PROTAC) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ARV-110 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PROteolysis Targeting Chimera (PROTAC) include Arvinas, Kymera, C4 therapeutics, Captor therapeutics, Vividion, Cullgen, Pfizer, Merck and Genentech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PROteolysis Targeting Chimera (PROTAC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PROteolysis Targeting Chimera (PROTAC) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PROteolysis Targeting Chimera (PROTAC) Market Segment Percentages, by Type, 2021 (%)
Global PROteolysis Targeting Chimera (PROTAC) Market Segment Percentages, by Application, 2021 (%)
Global PROteolysis Targeting Chimera (PROTAC) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies PROteolysis Targeting Chimera (PROTAC) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PROteolysis Targeting Chimera (PROTAC) revenues share in global market, 2021 (%)
Key companies PROteolysis Targeting Chimera (PROTAC) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies PROteolysis Targeting Chimera (PROTAC) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of PROteolysis Targeting Chimera (PROTAC) in global, including the following market information:
Global PROteolysis Targeting Chimera (PROTAC) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PROteolysis Targeting Chimera (PROTAC) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five PROteolysis Targeting Chimera (PROTAC) companies in 2021 (%)
The global PROteolysis Targeting Chimera (PROTAC) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ARV-110 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PROteolysis Targeting Chimera (PROTAC) include Arvinas, Kymera, C4 therapeutics, Captor therapeutics, Vividion, Cullgen, Pfizer, Merck and Genentech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PROteolysis Targeting Chimera (PROTAC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PROteolysis Targeting Chimera (PROTAC) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PROteolysis Targeting Chimera (PROTAC) Market Segment Percentages, by Type, 2021 (%)
- ARV-110
- ARV-471
- KYM-001
- Others
Global PROteolysis Targeting Chimera (PROTAC) Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Others
Global PROteolysis Targeting Chimera (PROTAC) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies PROteolysis Targeting Chimera (PROTAC) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PROteolysis Targeting Chimera (PROTAC) revenues share in global market, 2021 (%)
Key companies PROteolysis Targeting Chimera (PROTAC) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies PROteolysis Targeting Chimera (PROTAC) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Arvinas
- Kymera
- C4 therapeutics
- Captor therapeutics
- Vividion
- Cullgen
- Pfizer
- Merck
- Genentech
- AstraZeneca
- Amgen
- Bayer
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 PROteolysis Targeting Chimera (PROTAC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PROteolysis Targeting Chimera (PROTAC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PROTEOLYSIS TARGETING CHIMERA (PROTAC) OVERALL MARKET SIZE
2.1 Global PROteolysis Targeting Chimera (PROTAC) Market Size: 2021 VS 2028
2.2 Global PROteolysis Targeting Chimera (PROTAC) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PROteolysis Targeting Chimera (PROTAC) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top PROteolysis Targeting Chimera (PROTAC) Players in Global Market
3.2 Top Global PROteolysis Targeting Chimera (PROTAC) Companies Ranked by Revenue
3.3 Global PROteolysis Targeting Chimera (PROTAC) Revenue by Companies
3.4 Global PROteolysis Targeting Chimera (PROTAC) Sales by Companies
3.5 Global PROteolysis Targeting Chimera (PROTAC) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PROteolysis Targeting Chimera (PROTAC) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PROteolysis Targeting Chimera (PROTAC) Product Type
3.8 Tier 1, Tier 2 and Tier 3 PROteolysis Targeting Chimera (PROTAC) Players in Global Market
3.8.1 List of Global Tier 1 PROteolysis Targeting Chimera (PROTAC) Companies
3.8.2 List of Global Tier 2 and Tier 3 PROteolysis Targeting Chimera (PROTAC) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global PROteolysis Targeting Chimera (PROTAC) Market Size Markets, 2021 & 2028
4.1.2 ARV-110
4.1.3 ARV-471
4.1.4 KYM-001
4.1.5 Others
4.2 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue & Forecasts
4.2.1 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2022
4.2.2 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2023-2028
4.2.3 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
4.3 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales & Forecasts
4.3.1 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2022
4.3.2 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2023-2028
4.3.3 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
4.4 By Type - Global PROteolysis Targeting Chimera (PROTAC) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global PROteolysis Targeting Chimera (PROTAC) Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Others
5.2 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue & Forecasts
5.2.1 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2022
5.2.2 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2023-2028
5.2.3 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
5.3 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales & Forecasts
5.3.1 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2022
5.3.2 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2023-2028
5.3.3 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
5.4 By Application - Global PROteolysis Targeting Chimera (PROTAC) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global PROteolysis Targeting Chimera (PROTAC) Market Size, 2021 & 2028
6.2 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue & Forecasts
6.2.1 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2022
6.2.2 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2023-2028
6.2.3 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
6.3 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales & Forecasts
6.3.1 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2022
6.3.2 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2023-2028
6.3.3 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.4.2 By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.4.3 US PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.4.4 Canada PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.4.5 Mexico PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.5.2 By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.5.3 Germany PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.4 France PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.5 U.K. PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.6 Italy PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.7 Russia PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.8 Nordic Countries PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.9 Benelux PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.6.2 By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.6.3 China PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.4 Japan PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.5 South Korea PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.6 Southeast Asia PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.7 India PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.7.2 By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.7.3 Brazil PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.7.4 Argentina PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.8.3 Turkey PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8.4 Israel PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8.5 Saudi Arabia PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8.6 UAE PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Arvinas
7.1.1 Arvinas Corporate Summary
7.1.2 Arvinas Business Overview
7.1.3 Arvinas PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.1.4 Arvinas PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.1.5 Arvinas Key News
7.2 Kymera
7.2.1 Kymera Corporate Summary
7.2.2 Kymera Business Overview
7.2.3 Kymera PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.2.4 Kymera PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.2.5 Kymera Key News
7.3 C4 therapeutics
7.3.1 C4 therapeutics Corporate Summary
7.3.2 C4 therapeutics Business Overview
7.3.3 C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.3.4 C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.3.5 C4 therapeutics Key News
7.4 Captor therapeutics
7.4.1 Captor therapeutics Corporate Summary
7.4.2 Captor therapeutics Business Overview
7.4.3 Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.4.4 Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.4.5 Captor therapeutics Key News
7.5 Vividion
7.5.1 Vividion Corporate Summary
7.5.2 Vividion Business Overview
7.5.3 Vividion PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.5.4 Vividion PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.5.5 Vividion Key News
7.6 Cullgen
7.6.1 Cullgen Corporate Summary
7.6.2 Cullgen Business Overview
7.6.3 Cullgen PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.6.4 Cullgen PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.6.5 Cullgen Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.7.4 Pfizer PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.8.4 Merck PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Genentech
7.9.1 Genentech Corporate Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.9.4 Genentech PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.9.5 Genentech Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.10.4 AstraZeneca PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Key News
7.11 Amgen
7.11.1 Amgen Corporate Summary
7.11.2 Amgen PROteolysis Targeting Chimera (PROTAC) Business Overview
7.11.3 Amgen PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.11.4 Amgen PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.11.5 Amgen Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer PROteolysis Targeting Chimera (PROTAC) Business Overview
7.12.3 Bayer PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.12.4 Bayer PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
8 GLOBAL PROTEOLYSIS TARGETING CHIMERA (PROTAC) PRODUCTION CAPACITY, ANALYSIS
8.1 Global PROteolysis Targeting Chimera (PROTAC) Production Capacity, 2017-2028
8.2 PROteolysis Targeting Chimera (PROTAC) Production Capacity of Key Manufacturers in Global Market
8.3 Global PROteolysis Targeting Chimera (PROTAC) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PROTEOLYSIS TARGETING CHIMERA (PROTAC) SUPPLY CHAIN ANALYSIS
10.1 PROteolysis Targeting Chimera (PROTAC) Industry Value Chain
10.2 PROteolysis Targeting Chimera (PROTAC) Upstream Market
10.3 PROteolysis Targeting Chimera (PROTAC) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PROteolysis Targeting Chimera (PROTAC) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 PROteolysis Targeting Chimera (PROTAC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PROteolysis Targeting Chimera (PROTAC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PROTEOLYSIS TARGETING CHIMERA (PROTAC) OVERALL MARKET SIZE
2.1 Global PROteolysis Targeting Chimera (PROTAC) Market Size: 2021 VS 2028
2.2 Global PROteolysis Targeting Chimera (PROTAC) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PROteolysis Targeting Chimera (PROTAC) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top PROteolysis Targeting Chimera (PROTAC) Players in Global Market
3.2 Top Global PROteolysis Targeting Chimera (PROTAC) Companies Ranked by Revenue
3.3 Global PROteolysis Targeting Chimera (PROTAC) Revenue by Companies
3.4 Global PROteolysis Targeting Chimera (PROTAC) Sales by Companies
3.5 Global PROteolysis Targeting Chimera (PROTAC) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PROteolysis Targeting Chimera (PROTAC) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PROteolysis Targeting Chimera (PROTAC) Product Type
3.8 Tier 1, Tier 2 and Tier 3 PROteolysis Targeting Chimera (PROTAC) Players in Global Market
3.8.1 List of Global Tier 1 PROteolysis Targeting Chimera (PROTAC) Companies
3.8.2 List of Global Tier 2 and Tier 3 PROteolysis Targeting Chimera (PROTAC) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global PROteolysis Targeting Chimera (PROTAC) Market Size Markets, 2021 & 2028
4.1.2 ARV-110
4.1.3 ARV-471
4.1.4 KYM-001
4.1.5 Others
4.2 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue & Forecasts
4.2.1 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2022
4.2.2 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2023-2028
4.2.3 By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
4.3 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales & Forecasts
4.3.1 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2022
4.3.2 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2023-2028
4.3.3 By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
4.4 By Type - Global PROteolysis Targeting Chimera (PROTAC) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global PROteolysis Targeting Chimera (PROTAC) Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Others
5.2 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue & Forecasts
5.2.1 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2022
5.2.2 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2023-2028
5.2.3 By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
5.3 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales & Forecasts
5.3.1 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2022
5.3.2 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2023-2028
5.3.3 By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
5.4 By Application - Global PROteolysis Targeting Chimera (PROTAC) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global PROteolysis Targeting Chimera (PROTAC) Market Size, 2021 & 2028
6.2 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue & Forecasts
6.2.1 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2022
6.2.2 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2023-2028
6.2.3 By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
6.3 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales & Forecasts
6.3.1 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2022
6.3.2 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales, 2023-2028
6.3.3 By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.4.2 By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.4.3 US PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.4.4 Canada PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.4.5 Mexico PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.5.2 By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.5.3 Germany PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.4 France PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.5 U.K. PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.6 Italy PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.7 Russia PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.8 Nordic Countries PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.5.9 Benelux PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.6.2 By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.6.3 China PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.4 Japan PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.5 South Korea PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.6 Southeast Asia PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.6.7 India PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.7.2 By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.7.3 Brazil PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.7.4 Argentina PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales, 2017-2028
6.8.3 Turkey PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8.4 Israel PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8.5 Saudi Arabia PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
6.8.6 UAE PROteolysis Targeting Chimera (PROTAC) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Arvinas
7.1.1 Arvinas Corporate Summary
7.1.2 Arvinas Business Overview
7.1.3 Arvinas PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.1.4 Arvinas PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.1.5 Arvinas Key News
7.2 Kymera
7.2.1 Kymera Corporate Summary
7.2.2 Kymera Business Overview
7.2.3 Kymera PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.2.4 Kymera PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.2.5 Kymera Key News
7.3 C4 therapeutics
7.3.1 C4 therapeutics Corporate Summary
7.3.2 C4 therapeutics Business Overview
7.3.3 C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.3.4 C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.3.5 C4 therapeutics Key News
7.4 Captor therapeutics
7.4.1 Captor therapeutics Corporate Summary
7.4.2 Captor therapeutics Business Overview
7.4.3 Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.4.4 Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.4.5 Captor therapeutics Key News
7.5 Vividion
7.5.1 Vividion Corporate Summary
7.5.2 Vividion Business Overview
7.5.3 Vividion PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.5.4 Vividion PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.5.5 Vividion Key News
7.6 Cullgen
7.6.1 Cullgen Corporate Summary
7.6.2 Cullgen Business Overview
7.6.3 Cullgen PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.6.4 Cullgen PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.6.5 Cullgen Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.7.4 Pfizer PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.8.4 Merck PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Genentech
7.9.1 Genentech Corporate Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.9.4 Genentech PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.9.5 Genentech Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.10.4 AstraZeneca PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Key News
7.11 Amgen
7.11.1 Amgen Corporate Summary
7.11.2 Amgen PROteolysis Targeting Chimera (PROTAC) Business Overview
7.11.3 Amgen PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.11.4 Amgen PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.11.5 Amgen Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer PROteolysis Targeting Chimera (PROTAC) Business Overview
7.12.3 Bayer PROteolysis Targeting Chimera (PROTAC) Major Product Offerings
7.12.4 Bayer PROteolysis Targeting Chimera (PROTAC) Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
8 GLOBAL PROTEOLYSIS TARGETING CHIMERA (PROTAC) PRODUCTION CAPACITY, ANALYSIS
8.1 Global PROteolysis Targeting Chimera (PROTAC) Production Capacity, 2017-2028
8.2 PROteolysis Targeting Chimera (PROTAC) Production Capacity of Key Manufacturers in Global Market
8.3 Global PROteolysis Targeting Chimera (PROTAC) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PROTEOLYSIS TARGETING CHIMERA (PROTAC) SUPPLY CHAIN ANALYSIS
10.1 PROteolysis Targeting Chimera (PROTAC) Industry Value Chain
10.2 PROteolysis Targeting Chimera (PROTAC) Upstream Market
10.3 PROteolysis Targeting Chimera (PROTAC) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PROteolysis Targeting Chimera (PROTAC) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of PROteolysis Targeting Chimera (PROTAC) in Global Market
Table 2. Top PROteolysis Targeting Chimera (PROTAC) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PROteolysis Targeting Chimera (PROTAC) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PROteolysis Targeting Chimera (PROTAC) Revenue Share by Companies, 2017-2022
Table 5. Global PROteolysis Targeting Chimera (PROTAC) Sales by Companies, (K Units), 2017-2022
Table 6. Global PROteolysis Targeting Chimera (PROTAC) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PROteolysis Targeting Chimera (PROTAC) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers PROteolysis Targeting Chimera (PROTAC) Product Type
Table 9. List of Global Tier 1 PROteolysis Targeting Chimera (PROTAC) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PROteolysis Targeting Chimera (PROTAC) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2017-2022
Table 15. By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2023-2028
Table 16. By Application – Global PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2017-2022
Table 20. By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2023-2028
Table 21. By Region – Global PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2017-2022
Table 25. By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2023-2028
Table 26. By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 29. By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 30. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 33. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 34. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 37. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 38. By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 41. By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 46. Arvinas Corporate Summary
Table 47. Arvinas PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 48. Arvinas PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Kymera Corporate Summary
Table 50. Kymera PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 51. Kymera PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. C4 therapeutics Corporate Summary
Table 53. C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 54. C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Captor therapeutics Corporate Summary
Table 56. Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 57. Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Vividion Corporate Summary
Table 59. Vividion PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 60. Vividion PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Cullgen Corporate Summary
Table 62. Cullgen PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 63. Cullgen PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 66. Pfizer PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 69. Merck PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Genentech Corporate Summary
Table 71. Genentech PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 72. Genentech PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. AstraZeneca Corporate Summary
Table 74. AstraZeneca PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 75. AstraZeneca PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Amgen Corporate Summary
Table 77. Amgen PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 78. Amgen PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 81. Bayer PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. PROteolysis Targeting Chimera (PROTAC) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global PROteolysis Targeting Chimera (PROTAC) Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global PROteolysis Targeting Chimera (PROTAC) Production by Region, 2017-2022 (K Units)
Table 85. Global PROteolysis Targeting Chimera (PROTAC) Production by Region, 2023-2028 (K Units)
Table 86. PROteolysis Targeting Chimera (PROTAC) Market Opportunities & Trends in Global Market
Table 87. PROteolysis Targeting Chimera (PROTAC) Market Drivers in Global Market
Table 88. PROteolysis Targeting Chimera (PROTAC) Market Restraints in Global Market
Table 89. PROteolysis Targeting Chimera (PROTAC) Raw Materials
Table 90. PROteolysis Targeting Chimera (PROTAC) Raw Materials Suppliers in Global Market
Table 91. Typical PROteolysis Targeting Chimera (PROTAC) Downstream
Table 92. PROteolysis Targeting Chimera (PROTAC) Downstream Clients in Global Market
Table 93. PROteolysis Targeting Chimera (PROTAC) Distributors and Sales Agents in Global Market
Table 1. Key Players of PROteolysis Targeting Chimera (PROTAC) in Global Market
Table 2. Top PROteolysis Targeting Chimera (PROTAC) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PROteolysis Targeting Chimera (PROTAC) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PROteolysis Targeting Chimera (PROTAC) Revenue Share by Companies, 2017-2022
Table 5. Global PROteolysis Targeting Chimera (PROTAC) Sales by Companies, (K Units), 2017-2022
Table 6. Global PROteolysis Targeting Chimera (PROTAC) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PROteolysis Targeting Chimera (PROTAC) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers PROteolysis Targeting Chimera (PROTAC) Product Type
Table 9. List of Global Tier 1 PROteolysis Targeting Chimera (PROTAC) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PROteolysis Targeting Chimera (PROTAC) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2017-2022
Table 15. By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2023-2028
Table 16. By Application – Global PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2017-2022
Table 20. By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2023-2028
Table 21. By Region – Global PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2017-2022
Table 25. By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales (K Units), 2023-2028
Table 26. By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 29. By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 30. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 33. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 34. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 37. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 38. By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 41. By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales, (K Units), 2023-2028
Table 46. Arvinas Corporate Summary
Table 47. Arvinas PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 48. Arvinas PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Kymera Corporate Summary
Table 50. Kymera PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 51. Kymera PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. C4 therapeutics Corporate Summary
Table 53. C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 54. C4 therapeutics PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Captor therapeutics Corporate Summary
Table 56. Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 57. Captor therapeutics PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Vividion Corporate Summary
Table 59. Vividion PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 60. Vividion PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Cullgen Corporate Summary
Table 62. Cullgen PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 63. Cullgen PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 66. Pfizer PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 69. Merck PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Genentech Corporate Summary
Table 71. Genentech PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 72. Genentech PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. AstraZeneca Corporate Summary
Table 74. AstraZeneca PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 75. AstraZeneca PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Amgen Corporate Summary
Table 77. Amgen PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 78. Amgen PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer PROteolysis Targeting Chimera (PROTAC) Product Offerings
Table 81. Bayer PROteolysis Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. PROteolysis Targeting Chimera (PROTAC) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global PROteolysis Targeting Chimera (PROTAC) Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global PROteolysis Targeting Chimera (PROTAC) Production by Region, 2017-2022 (K Units)
Table 85. Global PROteolysis Targeting Chimera (PROTAC) Production by Region, 2023-2028 (K Units)
Table 86. PROteolysis Targeting Chimera (PROTAC) Market Opportunities & Trends in Global Market
Table 87. PROteolysis Targeting Chimera (PROTAC) Market Drivers in Global Market
Table 88. PROteolysis Targeting Chimera (PROTAC) Market Restraints in Global Market
Table 89. PROteolysis Targeting Chimera (PROTAC) Raw Materials
Table 90. PROteolysis Targeting Chimera (PROTAC) Raw Materials Suppliers in Global Market
Table 91. Typical PROteolysis Targeting Chimera (PROTAC) Downstream
Table 92. PROteolysis Targeting Chimera (PROTAC) Downstream Clients in Global Market
Table 93. PROteolysis Targeting Chimera (PROTAC) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. PROteolysis Targeting Chimera (PROTAC) Segment by Type
Figure 2. PROteolysis Targeting Chimera (PROTAC) Segment by Application
Figure 3. Global PROteolysis Targeting Chimera (PROTAC) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PROteolysis Targeting Chimera (PROTAC) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028 (US$, Mn)
Figure 7. PROteolysis Targeting Chimera (PROTAC) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by PROteolysis Targeting Chimera (PROTAC) Revenue in 2021
Figure 9. By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 10. By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 11. By Type - Global PROteolysis Targeting Chimera (PROTAC) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 13. By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 14. By Application - Global PROteolysis Targeting Chimera (PROTAC) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 16. By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 17. By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 18. By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 19. US PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 24. Germany PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 25. France PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 33. China PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 37. India PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 39. By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 40. Brazil PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 44. Turkey PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 48. Global PROteolysis Targeting Chimera (PROTAC) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production PROteolysis Targeting Chimera (PROTAC) by Region, 2021 VS 2028
Figure 50. PROteolysis Targeting Chimera (PROTAC) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. PROteolysis Targeting Chimera (PROTAC) Segment by Type
Figure 2. PROteolysis Targeting Chimera (PROTAC) Segment by Application
Figure 3. Global PROteolysis Targeting Chimera (PROTAC) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PROteolysis Targeting Chimera (PROTAC) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PROteolysis Targeting Chimera (PROTAC) Revenue, 2017-2028 (US$, Mn)
Figure 7. PROteolysis Targeting Chimera (PROTAC) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by PROteolysis Targeting Chimera (PROTAC) Revenue in 2021
Figure 9. By Type - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 10. By Type - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 11. By Type - Global PROteolysis Targeting Chimera (PROTAC) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 13. By Application - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 14. By Application - Global PROteolysis Targeting Chimera (PROTAC) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 16. By Region - Global PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 17. By Country - North America PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 18. By Country - North America PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 19. US PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 24. Germany PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 25. France PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 33. China PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 37. India PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 39. By Country - South America PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 40. Brazil PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PROteolysis Targeting Chimera (PROTAC) Sales Market Share, 2017-2028
Figure 44. Turkey PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PROteolysis Targeting Chimera (PROTAC) Revenue, (US$, Mn), 2017-2028
Figure 48. Global PROteolysis Targeting Chimera (PROTAC) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production PROteolysis Targeting Chimera (PROTAC) by Region, 2021 VS 2028
Figure 50. PROteolysis Targeting Chimera (PROTAC) Industry Value Chain
Figure 51. Marketing Channels
